SHINEWAY PHARM: TURNOVER FOR THE FIRST QUARTER OF 2024
SHINEWAY PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
SHINEWAY PHARM: Notification Letter to Non-registered Shareholders - Notice of Publication of 2023 Annual Report, Circular and Environmental, Social and Governance Report 2023
SHINEWAY PHARM: Notification Letter to Registered Shareholders - Notice of Publication of 2023 Annual Report, Circular, Proxy Form and Environmental, Social and Governance Report 2023
SHINEWAY PHARM: ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2023
SHINEWAY PHARM: NOTICE OF ANNUAL GENERAL MEETING
SHINEWAY PHARM: Form of proxy for use at the annual general meeting to be held on Friday, 31 May 2024 (or at any adjournment thereof)
SHINEWAY PHARM: PROPOSALS FOR GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES, RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
SHINEWAY PHARM: Annual report 2023
SHINEWAY PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
SHINEWAY PHARM: 2023 ANNUAL RESULTS ANNOUNCEMENT AND DECLARATION OF 2024 FIRST INTERIM DIVIDEND
SHINEWAY PHARM: First interim dividend in respect of the fiscal year 2024
SHINEWAY PHARM: Notice of Board Meeting
SHINEWAY PHARM: NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS WITH REPLY FORM - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS
SHINEWAY PHARM: NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS WITH REPLY FORM - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS
SHINEWAY PHARM: POSITIVE PROFIT ALERT
SHINEWAY PHARM: POSITIVE PROFIT ALERT
SHINEWAY PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
SHINEWAY PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
SHINEWAY PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
No Data